U
Nirvana Life Sciences Inc. NIRVF
$0.0083 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
--
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

10/31/2024 07/31/2024 04/30/2024 01/31/2024 10/31/2023
Net Income 68.95% 64.36% 41.89% 80.03% 76.30%
Total Depreciation and Amortization -60.18% -73.58% -80.41% -63.05% -52.39%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -93.50% -91.22% -54.91% -83.78% -80.89%
Change in Net Operating Assets 84.15% 42.42% -7.60% -85.12% -68.65%
Cash from Operations 83.78% 73.04% 44.02% -29.27% 37.74%
Capital Expenditure -- -- -- -- --
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -- --
Total Debt Issued 315.97% -56.03% -43.60% 90.46% -80.81%
Total Debt Repaid 200.00% 204.82% -- -124.15% --
Issuance of Common Stock -100.00% -91.53% -19.16% 113.33% 113.33%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 200.00% 200.00% -- -- --
Cash from Financing -82.12% -83.23% -43.18% -5.41% 24.39%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -324.24% -108.09% 56.21% 98.52% 104.46%
Weiss Ratings